Provisions of the Inflation Reduction Act of 2022 will favorably impact prescription drug prices and other healthcare costs for Medicare participants. While it will take several years to realize the full benefit of the law (including the $2,000 cap on total out-of-pocket drug costs in 2025) there are a number of immediate changes in 2023 […]